AnaptysBio trumpeted a Phase 2b success in rheumatoid arthritis Wednesday morning after a similar program from Eli Lilly was discontinued late last year.

JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web ...

Take­da has end­ed the man­u­fac­tur­ing and sup­ply of its gout drug Uloric in the US mar­ket as more pa­tients turn to gener­ic ver­sions, the com­pa­ny … ...